NCT06328166View on ClinicalTrials.gov

The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 22, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Carpal Tunnel Syndrome
Interventions
PROCEDURE

Sono-guided injection with ES135

Sono-guided injection with ES135 between carpal tunnel and median nerve

PROCEDURE

Sono-guided injection with placebo

Sono-guided injection with placebo between carpal tunnel and median nerve

Trial Locations (1)

114

No. 325, Sec. 2, Chenggong Rd., Neihu Dist., Taipei

Sponsors

Collaborators (1)

Eusol Biotech Co., Ltd.
All Listed Sponsors
collaborator

Eusol Biotech Co., Ltd.

INDUSTRY

lead

Tri-Service General Hospital

OTHER